These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 2545783)

  • 21. Analysis of solute diffusion across the C5b-9 membrane lesion of complement: evidence that individual C5b-9 complexes do not function as discrete, uniform pores.
    Sims PJ; Lauf PK
    J Immunol; 1980 Dec; 125(6):2617-25. PubMed ID: 7430641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxidants generated by the myeloperoxidase-halide system activate the fifth component of human complement, C5.
    Vogt W; Hesse D
    Immunobiology; 1994 Dec; 192(1-2):1-9. PubMed ID: 7750983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leukocyte complement: a possible role for C5 in lymphocyte stimulation.
    Sundsmo JS
    J Immunol; 1983 Aug; 131(2):886-91. PubMed ID: 6223096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predominant role for C5b-9 in renal ischemia/reperfusion injury.
    Zhou W; Farrar CA; Abe K; Pratt JR; Marsh JE; Wang Y; Stahl GL; Sacks SH
    J Clin Invest; 2000 May; 105(10):1363-71. PubMed ID: 10811844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The terminal membrane C5b-9 complex of human complement. Evidence for the existence of multiple protease-resistant polypeptides that form the trans-membrane complement channel.
    Bhakdi S; Tranum-Jensen J; Klump O
    J Immunol; 1980 May; 124(5):2451-7. PubMed ID: 6154104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of TraT protein, an anticomplementary protein produced in Escherichia coli by R100 factor, in serum resistance.
    Pramoonjago P; Kaneko M; Kinoshita T; Ohtsubo E; Takeda J; Hong KS; Inagi R; Inoue K
    J Immunol; 1992 Feb; 148(3):827-36. PubMed ID: 1730875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new activity of complement component C3: cell-bound C3b potentiates lysis of erythrocytes by C5b,6 and terminal components.
    Hammer CH; Abramovitz AS; Mayer MM
    J Immunol; 1976 Sep; 117(3):830-4. PubMed ID: 956655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human monocyte spreading induced by activated factor B of the complement alternative pathway: differential effects of Fab' and F(ab')2 antibody fragments directed to C5, C6, and C7.
    Sundsmo JS; Götze O
    Cell Immunol; 1983 Apr; 77(1):176-86. PubMed ID: 6601526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of anti-C5a antibodies on human polymorphonuclear leukocyte function: chemotaxis, chemiluminescence, and lysosomal enzyme release.
    Hatherill JR; Stephens KE; Nagao K; Ishizaka A; Wilmarth L; Wang JC; Deinhart T; Larrick JW; Raffin TA
    J Biol Response Mod; 1989 Dec; 8(6):614-24. PubMed ID: 2600603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The C5b-9 complex: subunit composition of the classical and alternative pathway-generated complex.
    Podack ER; Kolb WP; Muller-Eberhard HJ
    J Immunol; 1976 May; 116(5):1431-4. PubMed ID: 1270802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of complement fragment C5a in milk is variable among cows.
    Rainard P; Poutrel B
    J Dairy Sci; 2000 May; 83(5):945-51. PubMed ID: 10821569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of immune haemolysis by a serum factor found in C3-deficient subjects.
    Kitamura H; Tsuboi M
    Immunology; 1989 Feb; 66(2):264-9. PubMed ID: 2925225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunoenzyme determination of the C5b-9 complex of the complement system].
    Rus H; Niculescu F; Cristea A; Vlaicu R
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1986; 31(1):35-40. PubMed ID: 3738363
    [No Abstract]   [Full Text] [Related]  

  • 35. C5-dependent enhancement of rosette formation and phagocytosis by human polymorphonuclear leukocytes.
    Segerling M; Opferkuch W
    Monogr Allergy; 1977; 12():101-4. PubMed ID: 917012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteolysis of the C5b-7 complex: cleavage of the C5b and C6 subunits and its effect on the interaction of the complex with phospholipid bilayers.
    Yamamoto KI
    J Immunol; 1980 Oct; 125(4):1745-50. PubMed ID: 6997387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Size of the transmembrane channels produced by complement proteins C5b-8.
    Ramm LE; Whitlow MB; Mayer MM
    J Immunol; 1982 Sep; 129(3):1143-6. PubMed ID: 6286757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergism between zymosan-activated serum and heparin in the induction of polymorphonuclear leukocyte aggregation.
    Berliner S; Fishelson Z; Wasserman L; Pinkhas J; Aronson M
    Biomed Pharmacother; 1988; 42(1):69-72. PubMed ID: 3408808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human polymorphonuclear leukocytes store large amounts of terminal complement components C7 and C6, which may be released on stimulation.
    Høgåsen AK; Würzner R; Abrahamsen TG; Dierich MP
    J Immunol; 1995 May; 154(9):4734-40. PubMed ID: 7722325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human platelet-initiated formation and uptake of the C5-9 complex of human complement.
    Zimmerman TS; Kolb WP
    J Clin Invest; 1976 Jan; 57(1):203-11. PubMed ID: 812888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.